RSDL
Received Apr 20, 2023
Report 3009169861-2023-00041 · MDR key 16778326
Device
Product problems
- Leak/Splash
- Leak/Splash
Patient
Unknown
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Description of Event or Problem
LEAKING RSDL PACKETS [DEVICE LEAKAGE] . CASE NARRATIVE: ON (B)(6) 2022, A SPONTANEOUS REPORT WAS RECEIVED FROM A LOCAL GOVERNMENT SERVICE ORGANIZATION REGARDING LEAKING RSDL PACKETS (DEKON 139, METHOXYPOLYETHYLENE GLYCOL 550, 2,3 BUTANEDIONE MONOXIME) (PT: DEVICE LEAKAGE); LOT NUMBER: 23004643. THE REPORTER STATED, THAT THEY HAVE SOME PACKETS OF RSDL FROM BATCH 23004643, WHICH ARE LEAKING. NO ADVERSE EVENTS WERE REPORTED RELATED TO THE LEAKING PACKETS. NO FURTHER INFORMATION WAS PROVIDED. COMPANY COMMENT: IT WAS REPORTED, THAT SOME RSDL PACKETS WERE LEAKING (PT: DEVICE LEAKAGE). RSDL IS INTENDED TO BE USED FOR THE DECONTAMINATION OF SKIN EXPOSED TO CHEMICAL WARFARE AGENTS (CWA) AND T-2 TOXIN. AN RSDL PACKET THAT LEAKS COULD MAKE THE COMPOSITION OF THE PACKET DRY OUT OR LESS RSDL AVAILABLE AND THAT MAY AFFECT THE EFFICACY OF THE DEVICE. IN A SITUATION WHEREBY AN INDIVIDUAL IS EXPOSED TO CWA AND NEEDS IMMEDIATE DECONTAMINATION WITH RSDL, THERE EXISTS THE POSSIBILITY OF A LACK OF EFFICACY OF THE DEVICE WHICH WILL MAKE THE PERSON VULNERABLE TO HEALTH HAZARDS FROM THE CWA OR T-2 TOXIN. WHILE PACKET LEAKS HAVE BEEN KNOWN TO OCCUR, A RISK/BENEFIT POSITION POINTS TO A REDUCTION IN RISK FROM A CHEMICAL WARFARE ATTACK ,EVEN IF USING A LEAKING AND/OR DELAMINATED PACKET OF RSDL.
Remedial action
- Inspection